These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 10662477

  • 1. Cost effectiveness of fluticasone propionate and flunisolide in the treatment of corticosteroid-naive patients with moderate asthma.
    Volmer T, Kielhorn A, Weber HH, Wiessmann KJ.
    Pharmacoeconomics; 1999 Nov; 16(5 Pt 2):525-31. PubMed ID: 10662477
    [Abstract] [Full Text] [Related]

  • 2. Improved asthma control after changing from low-to-medium doses of other inhaled corticosteroids to low-dose fluticasone propionate.
    Stoloff SW, Srebro SH, Edwards LD, Johnson MC, Rickard KA.
    MedGenMed; 2001 Jun 08; 3(3):2. PubMed ID: 11549975
    [Abstract] [Full Text] [Related]

  • 3. Cost-effectiveness comparison of salmeterol/fluticasone propionate versus montelukast in the treatment of adults with persistent asthma.
    Sheth K, Borker R, Emmett A, Rickard K, Dorinsky P.
    Pharmacoeconomics; 2002 Jun 08; 20(13):909-18. PubMed ID: 12381242
    [Abstract] [Full Text] [Related]

  • 4. Effects of the inhaled corticosteroids fluticasone propionate, triamcinolone acetonide, and flunisolide and oral prednisone on the hypothalamic-pituitary-adrenal axis in adult patients with asthma.
    Sorkness CA, LaForce C, Storms W, Lincourt WR, Edwards L, Rogenes PR.
    Clin Ther; 1999 Feb 08; 21(2):353-67. PubMed ID: 10211538
    [Abstract] [Full Text] [Related]

  • 5. Salmeterol/fluticasone propionate versus fluticasone propionate plus montelukast: a cost-effective comparison for asthma.
    Pieters WR, Wilson KK, Smith HC, Tamminga JJ, Sondhi S.
    Treat Respir Med; 2005 Feb 08; 4(2):129-38. PubMed ID: 15813665
    [Abstract] [Full Text] [Related]

  • 6. Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthma.
    O'Connor RD, Nelson H, Borker R, Emmett A, Jhingran P, Rickard K, Dorinsky P.
    Pharmacoeconomics; 2004 Feb 08; 22(12):815-25. PubMed ID: 15294013
    [Abstract] [Full Text] [Related]

  • 7. Inhaled fluticasone propionate. A pharmacoeconomic review of its use in the management of asthma.
    Lamb HM, Culy CR, Faulds D.
    Pharmacoeconomics; 2000 Nov 08; 18(5):487-510. PubMed ID: 11151402
    [Abstract] [Full Text] [Related]

  • 8. Cost-efficacy analysis of fluticasone propionate versus zafirlukast in patients with persistent asthma.
    Menendez R, Stanford RH, Edwards L, Kalberg C, Rickard K.
    Pharmacoeconomics; 2001 Nov 08; 19(8):865-74. PubMed ID: 11596838
    [Abstract] [Full Text] [Related]

  • 9. Inhaled salmeterol/fluticasone propionate combination: a pharmacoeconomic review of its use in the management of asthma.
    Lyseng-Williamson KA, Plosker GL.
    Pharmacoeconomics; 2003 Nov 08; 21(13):951-89. PubMed ID: 12959627
    [Abstract] [Full Text] [Related]

  • 10. Cost-effectiveness of salmeterol/fluticasone propionate combination product 50/250 microg twice daily and budesonide 800 microg twice daily in the treatment of adults and adolescents with asthma. International Study Group.
    Lundbäck B, Jenkins C, Price MJ, Thwaites RM.
    Respir Med; 2000 Jul 08; 94(7):724-32. PubMed ID: 10926346
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the efficacy of inhaled fluticasone propionate, 880 microg/day, with flunisolide, 1500 microg/day, in moderate-to-severe persistent asthma.
    Sheikh S, Goldsmith LJ, Howell L, Eid N.
    Ann Allergy Asthma Immunol; 1999 Oct 08; 83(4):300-4. PubMed ID: 10541421
    [Abstract] [Full Text] [Related]

  • 12. The cost-effectiveness of inhaled fluticasone propionate and budesonide in the treatment of asthma in adults and children.
    Barnes NC, Thwaites RM, Price MJ.
    Respir Med; 1999 Jun 08; 93(6):402-7. PubMed ID: 10464822
    [Abstract] [Full Text] [Related]

  • 13. Suppression of hypothalamic-pituitary-adrenal axis activity with inhaled flunisolide and fluticasone propionate in adult asthma patients.
    Casale TB, Nelson HS, Stricker WE, Raff H, Newman KB.
    Ann Allergy Asthma Immunol; 2001 Nov 08; 87(5):379-85. PubMed ID: 11730179
    [Abstract] [Full Text] [Related]

  • 14. Inhaled salmeterol/fluticasone propionate combination. A pharmacoeconomic review of its use in the management of asthma.
    Markham A, Adkins JC.
    Pharmacoeconomics; 2000 Dec 08; 18(6):591-608. PubMed ID: 11227397
    [Abstract] [Full Text] [Related]

  • 15. COST-effectiveness of salmeterol/fluticasone propionate combination (Advair(®)) in uncontrolled asthma in Canada.
    Ismaila AS, Risebrough N, Li C, Corriveau D, Hawkins N, FitzGerald JM, Su Z.
    Respir Med; 2014 Sep 08; 108(9):1292-302. PubMed ID: 25175480
    [Abstract] [Full Text] [Related]

  • 16. Cost-efficacy comparison of inhaled fluticasone propionate and budesonide in the treatment of asthma.
    Stempel DA, Stanford RH, Thwaites R, Price MJ.
    Clin Ther; 2000 Dec 08; 22(12):1562-74. PubMed ID: 11192147
    [Abstract] [Full Text] [Related]

  • 17. Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma.
    Peden DB, Berger WE, Noonan MJ, Thomas MR, Hendricks VL, Hamedani AG, Mahajan P, House KW.
    J Allergy Clin Immunol; 1998 Jul 08; 102(1):32-8. PubMed ID: 9679845
    [Abstract] [Full Text] [Related]

  • 18. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
    Markham A, Jarvis B.
    Drugs; 2000 Nov 08; 60(5):1207-33. PubMed ID: 11129128
    [Abstract] [Full Text] [Related]

  • 19. Development of an economic model to assess the cost effectiveness of asthma management strategies.
    Price MJ, Briggs AH.
    Pharmacoeconomics; 2002 Nov 08; 20(3):183-94. PubMed ID: 11929348
    [Abstract] [Full Text] [Related]

  • 20. Effectiveness of fluticasone propionate in patients with moderate asthma: a dose-ranging study.
    Wolfe JD, Selner JC, Mendelson LM, Hampel F, Schaberg A.
    Clin Ther; 1996 Nov 08; 18(4):635-46. PubMed ID: 8879892
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.